Nurix Therapeutics, Inc. NRIX Investments
Investments at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s investments?
- Nurix Therapeutics, Inc. (NRIX) reported investments of $469.48M in Q4 2025.
- What is the long-term trend for Nurix Therapeutics, Inc.'s investments?
- Over 3 years (2022 to 2025), Nurix Therapeutics, Inc.'s investments has grown at a 12.2% compound annual growth rate (CAGR), from $244.67M to $345.88M.
- What does investments mean?
- This represents the total amortized cost of debt securities classified as available-for-sale, excluding any adjustments for fair value changes. It provides a baseline for the capital deployed into interest-bearing instruments. This metric is essential for understanding the scale of the company's conservative investment strategy and liquidity management.